Dabur India Limited — FDA Class II (D-0633-2026)

Dabur India Limited is recalling 84 tubes of a drug due to CGMP (Current Good Manufacturing Practice) deviations. The recall is classified as a voluntary action. The geographic scope of the recall is not specified.

• •Dabur India Limited is recalling 84 tubes of a drug.
• •The recall is due to CGMP deviations.
• •This is classified as a Class II recall.
• •Consumers should check their medicine cabinets for the recalled product.

Consumers who purchased the recalled drug should stop using it and contact the firm for further instructions. The recall affects a total of 84 tubes.